Precursor Control Regulations (SOR/2002-359)
Full Document:
- HTMLFull Document: Precursor Control Regulations (Accessibility Buttons available) |
- XMLFull Document: Precursor Control Regulations [295 KB] |
- PDFFull Document: Precursor Control Regulations [667 KB]
Regulations are current to 2024-08-18 and last amended on 2023-11-24. Previous Versions
SCHEDULE(Paragraph 5(b), section 8, subsections 9(1.1) and 91.3(1), section 91.9, subsection 91.92(1), paragraph 91.96(c) and section 92)
Column 1 | Column 2 | |
---|---|---|
Item | Precursor set out in Part 1 of Schedule VI to the Act | Maximum Quantity (expressed as an absolute amount or per package) |
1 | Acetic anhydride | 1000 kg |
2 | N-Acetylanthranilic acid (2-acetamidobenzoic acid) | 1 kg |
3 | Anthranilic acid (2-aminobenzoic acid) | 1 kg |
4 | Ephedra | 20 g per package |
5 | Ephedrine (erythro-2-(methylamino)-1-phenyl-propan-1-ol) | 0.4 g per package |
6 | Ergometrine (9,10-didehydro-N-(2-hydroxy-1-methylethyl)-6-methylergoline-8-carboxamide) | 0 |
7 | Ergotamine (12′-hydroxy-2′-methyl-5′-(phenylmethyl)ergotaman-3′,6′,18-trione) | 0 |
8 | Isosafrole (5-(1-propenyl)-1,3-benzodioxole) | 0.5 kg |
9 | Lysergic acid (9,10-didehydro-6-methylergoline-8-carboxylic acid) | 0 |
10 | 3,4-Methylenedioxyphenyl-2- propanone (1-(1,3- benzodioxole)-2-propanone), its derivatives and analogues and salts of derivatives and analogues, including:
| 0 |
11 | Norephedrine (Phenylpropanolamine) | 0 |
12 | Phenylacetic acid | 1 kg |
13 | 1-Phenyl-2-propanone, its derivatives and analogues and salts of derivatives and analogues, including:
| 0 |
14 | Piperidine | 0.5 kg |
15 | Piperonal (1,3-benzodioxole-5-carboxaldehyde) | 0.5 kg |
16 | Potassium permanganate | 50 kg |
17 | Pseudoephedrine (threo-2-(methylamino)-1-phenyl-propan-1-ol) | 3 g per package |
18 | Safrole (5-(2-propenyl)-1,3-benzodioxole) | 0.25 kg |
19 | Gamma-butyrolactone (dihydro-2(3H)- furanone) | 0 |
20 | 1,4-butanediol | 0 |
21 | Red Phosphorus | 0 |
22 | White Phosphorus | 0 |
23 | Hypophosphorous acid, its salts and derivatives | 0 |
24 | Hydriodic acid | 0 |
25 | Alpha-phenylacetoacetonitrile and its salts, isomers and salts of isomers | 0 |
26 | Propionyl chloride | 0 |
27 | 1-Phenethyl-4-piperidone and its salts | 0 |
28 | 4-Piperidone and its salts | 0 |
29 | Norfentanyl (N-phenyl-N-piperidin- 4-ylpropanamide), its salts, derivatives and analogues and salts of derivatives and analogues | 0 |
30 | 1-Phenethylpiperidin-4-ylidenephenylamine and its salts | 0 |
31 | N-Phenyl-4-piperidinamine (N-phenylpiperidin-4-amine), its salts, derivatives and analogues and salts of derivatives and analogues, including:
| 0 |
32 | N1,N1,N2-trimethylcyclohexane-1,2-diamine and its salts | 0 |
33 | Benzylfentanyl (N-(1-benzylpiperidin-4-yl)-N-phenylpropionamide), its salts, derivatives and analogues and salts of derivatives and analogues | 0 |
- SOR/2005-365, ss. 59, 60
- SOR/2016-12, ss. 1, 2(F), 3
- SOR/2016-294, s. 1
- SOR/2017-278, s. 2
- SOR/2019-120, s. 2
- SOR/2019-120, s. 3
- SOR/2019-120, s. 4
- SOR/2019-120, s. 5
- SOR/2023-102, s. 1
- SOR/2023-247, s. 13(F)
- Date modified: